Pharmaceutical Commerce - November/December 2009 - (Page 4)

Contents VOL. 4, NO. 9 Brand marketing|Communications 14 Industry Tackles the New remS Hurdle FDA’s requirements for risk evaluation and mitigation challenge both new and existing commercialization processes Founder/editorial director Nicholas Basta 718 282 6112, nbasta@PharmaceuticalCommerce.com Publisher Alan Morris 516 869 0334, amorris@PharmaceuticalCommerce.com Contributing editors Angelo DePalma, Mike Faden, George Miller, F.J. Quinn, Suzanne Shelley editorial Board Jeffrey Berkowitz, Schering-Plough Corp. Richard Carlson, Blue Fin Group Liz Coyle, IMS Health Adam Fein, Pembroke Consulting Marita Gomez, Purohit Navigation Rich Minoff, 1 Global Partners John Rhodes, Deloitte Mark Seitz, Eli Lilly & Co. Daniel Steiber, D2 Pharma Advertising representatives New england Vince Cavaseno 617 232 2000, vince@spaceage1.com midwest David Gerchen 314 878 3939, dgerchen@gmail.com Southeast Charlton Calhoun calhoun4@aol.com West Richard Ayer 949 366 9089, ayercomm@earthlink.net Jane Hayward 949 366 2457, janehayward@earthlink.net Or, contact Publisher Alan Morris at 516 869 0334, amorris@PharmaceuticalCommerce.com Botox Lawsuit Highlights Another Wrinkle for remS How to ensure Successful design and Implementation of Physician Segmentation The basic process of defining customer segments and appropriate promotional messaging benefits from a cross-disciplinary approach editorial 6 op-ed 7 Can Fair Balance exist on the Web? FDA struggles with the new world of social media Cargo Theft emerges as a New Biopharma Worry The signs are apparent that there is organized criminal activity focused on pharma logistics Supply Chain | Logistics 19 Information Technology 21 Impax Labs enjoys the Fruits of Its IBm Cognos Investment With limited IT resources, the company is rolling out one business-intelligence application after another Short Takes Specialty Pharmacy Providers deserve Their own Class of Trade The emergence of specialty pharmacies, with fundamental differences from other types of pharmacy providers, warrants the establishment of manufacturer relationships Transparency Is the Solution to the medical-Journal ‘Ghostwriting’ Controversy Drug companies should keep a goal of effective communications as the priority in medical publications Top News 8 HdmA Analyzes evolving Specialty distribution Business Survey shows close interplay between manufacturers and their trading partners for supplemental services UPS and Genzyme: A Pioneering drug Serialization Initiative Amr research Selects ‘Healthcare Top 25’ for Supply Chain excellence Fifteen of top 25 are drug or device makers; hospitals and distributors round out the list from the new Gartner subsidiary Cardinal Health Tailors Pharma deliveries to High-volume mail-order Pharmacies Addition of EZ-Cart system drastically cuts restocking efforts Now, Use Patient-Level data to measure Advertising-media effectiveness SDI Health extends its longitudinal patient analytics to measure media impacts UCB offers Tailored Syringe for rheumatoid Arthritis Patients The dilemma: packaging a drug for a condition that makes self-administration difficult Packaging & drug delivery 22 Pharma Gets a ‘Just in Time’ Speedup With the Switch to digital Printing ‘Print on demand’ changes traditional design,production and inventory practices for labels, inserts and other printed packaging readying Packaging Lines for data management Schering-Plough implements packaging line vision technology with a view toward future data collection needs vetter opens Injectables Packaging Facility in Illinois Healthcare Commerce media Corporation Pharmaceutical Commerce is published by Healthcare Commerce Media Corp., 85 Westminster Rd., Brooklyn, NY 11218. editorial queries: 718 282 6112, or info@PharmaceuticalCommerce.com. Copyright 2009. All rights reserved. Printed in the United States of America. Send all subscription inquiries or requests to Subscriptions, Pharmaceutical Commerce, 85 Westminster Rd., Brooklyn, NY 11218. The management and editors of Pharmaceutical Commerce make every effort to publish accurate information. However, neither the management, editorial board, editors or reporters can be held liable for erroneous information. Opinions of Pharmaceutical Commerce columnists are their own, and do not necessarily represent those of employees or other contributors to Pharmaceutical Commerce. Advertising queries please direct to: Alan R. Morris, Pharmaceutical Commerce, Inc., 22 Bayview Avenue, Manhasset, NY 11030; tel: 516 869 0334, fax: 516 869 0325, sales@PharmaceuticalCommerce.com www.PharmaceuticalCommerce.com Business & Finance 12 Generic manufacturers Gain Another Advantage in disputing drug Patents FDA sets a precedent for granting generic approvals even when initial litigation goes against the generic manufacturer QPharma and Solabs Will Partner to Provide Compliance Services Legal | regulatory 26 Getting value From end-of-Life-Cycle Pharmaceuticals A review of 84 branded pharmaceutical products with changed ownership as of 2005 shows that many of them can continue to sell, often with much higher prices executive Training & development 28 People on the move editorial Index | meetings 31 4 NovemBer/deCemBer 2009 www.PharmaceuticalCommerce.com http://www.PharmaceuticalCommerce.com http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - November/December 2009

Pharmaceutical Commerce - November/December 2009
Contents
Editorial
Op-Ed
Top News
Business & Finance
Brand Marketing | Communications
SupplyChain | Logistics
Information Technology
Packaging & Drug Delivery
Legal | Regulatory
Executive Training & Development
Editorial Index | Meetings

Pharmaceutical Commerce - November/December 2009

https://www.nxtbook.com/nxtbooks/pharmcomm/202006
https://www.nxtbook.com/nxtbooks/pharmcomm/202003
https://www.nxtbook.com/nxtbooks/pharmcomm/201911
https://www.nxtbook.com/nxtbooks/pharmcomm/201909
https://www.nxtbook.com/nxtbooks/pharmcomm/201906
https://www.nxtbook.com/nxtbooks/pharmcomm/201903
https://www.nxtbook.com/nxtbooks/pharmcomm/201811
https://www.nxtbook.com/nxtbooks/pharmcomm/201809
https://www.nxtbook.com/nxtbooks/pharmcomm/201806
https://www.nxtbook.com/nxtbooks/pharmcomm/20180304
https://www.nxtbook.com/nxtbooks/pharmcomm/20171112
https://www.nxtbook.com/nxtbooks/pharmcomm/20170910
https://www.nxtbook.com/nxtbooks/pharmcomm/20170708
https://www.nxtbook.com/nxtbooks/pharmcomm/20170506
https://www.nxtbook.com/nxtbooks/pharmcomm/20170304
https://www.nxtbook.com/nxtbooks/pharmcomm/20170102
https://www.nxtbook.com/nxtbooks/pharmcomm/20161112
https://www.nxtbook.com/nxtbooks/pharmcomm/20160910
https://www.nxtbook.com/nxtbooks/pharmcomm/20160708
https://www.nxtbook.com/nxtbooks/pharmcomm/20160506
https://www.nxtbook.com/nxtbooks/pharmcomm/20160304
https://www.nxtbook.com/nxtbooks/pharmcomm/20160102
https://www.nxtbook.com/nxtbooks/pharmcomm/20151112
https://www.nxtbook.com/nxtbooks/pharmcomm/20150910
https://www.nxtbook.com/nxtbooks/pharmcomm/20150708
https://www.nxtbook.com/nxtbooks/pharmcomm/20150506
https://www.nxtbook.com/nxtbooks/pharmcomm/20150304
https://www.nxtbook.com/nxtbooks/pharmcomm/20150102
https://www.nxtbook.com/nxtbooks/pharmcomm/20141112
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
https://www.nxtbook.com/nxtbooks/pharmcomm/20140910
https://www.nxtbook.com/nxtbooks/pharmcomm/20140708
https://www.nxtbook.com/nxtbooks/pharmcomm/20140506
https://www.nxtbook.com/nxtbooks/pharmcomm/20140304
https://www.nxtbook.com/nxtbooks/pharmcomm/20140102
https://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
https://www.nxtbook.com/nxtbooks/pharmcomm/20131112
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910
https://www.nxtbook.com/nxtbooks/pharmcomm/20130708
https://www.nxtbook.com/nxtbooks/pharmcomm/20130506
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
https://www.nxtbook.com/nxtbooks/pharmcomm/20130304
https://www.nxtbook.com/nxtbooks/pharmcomm/20130102
https://www.nxtbook.com/nxtbooks/pharmcomm/20121112
https://www.nxtbook.com/nxtbooks/pharmcomm/20120910
https://www.nxtbook.com/nxtbooks/pharmcomm/20120708
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
https://www.nxtbook.com/nxtbooks/pharmcomm/20120304
https://www.nxtbook.com/nxtbooks/pharmcomm/20120102
https://www.nxtbook.com/nxtbooks/pharmcomm/20111112
https://www.nxtbook.com/nxtbooks/pharmcomm/20110910
https://www.nxtbook.com/nxtbooks/pharmcomm/20110708
https://www.nxtbook.com/nxtbooks/pharmcomm/20110506
https://www.nxtbook.com/nxtbooks/pharmcomm/20110304
https://www.nxtbook.com/nxtbooks/pharmcomm/20110102
https://www.nxtbook.com/nxtbooks/pharmcomm/20101112
https://www.nxtbook.com/nxtbooks/pharmcomm/20100910
https://www.nxtbook.com/nxtbooks/pharmcomm/20100708
https://www.nxtbook.com/nxtbooks/pharmcomm/20100506
https://www.nxtbook.com/nxtbooks/pharmcomm/201004
https://www.nxtbook.com/nxtbooks/pharmcomm/201003
https://www.nxtbook.com/nxtbooks/pharmcomm/20100102
https://www.nxtbook.com/nxtbooks/pharmcomm/20091112
https://www.nxtbookmedia.com